Home > Panel of experts > Interview Alain HORVAIS
Alain HORVAIS
Partner in charge of the diagnostics fund, Kurma Life Sciences
« Risks and limits for the industrial development of complex biomarkers »
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Preference cookies are used to store user preferences to provide content that is customized and convenient for the users, like the language of the website or the location of the visitor.